 | • レポートコード：QYR2104Z1652 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、94ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥565,500 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥848,250 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,131,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、クローン病診断・治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（血液検査、糞便検査、結腸内視鏡検査、フレキシブルS状結腸鏡検査、コンピューター断層撮影、磁気共鳴画像法、カプセル内視鏡検査）、用途別市場規模（クリニック、病院）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・クローン病診断・治療の市場動向 ・企業の競争状況、市場シェア ・クローン病診断・治療の種類別市場規模（血液検査、糞便検査、結腸内視鏡検査、フレキシブルS状結腸鏡検査、コンピューター断層撮影、磁気共鳴画像法、カプセル内視鏡検査） ・クローン病診断・治療の用途別市場規模（クリニック、病院） ・クローン病診断・治療の北米市場規模2016-2027（アメリカ、カナダ） ・クローン病診断・治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・クローン病診断・治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・クローン病診断・治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・クローン病診断・治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（AbbVie、Celgene Corporation、Genetech、Janssen Biotech、Johnson & Johnson、Pfizer、Prometheus Laboratories、Salix Pharmaceuticals、Takeda's Pharmaceutical） ・結論 |
Market Analysis and Insights: Global Crohn’s Disease Diagnostic and Therapeutic Market
The global Crohn’s Disease Diagnostic and Therapeutic market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Crohn’s Disease Diagnostic and Therapeutic market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Crohn’s Disease Diagnostic and Therapeutic market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Crohn’s Disease Diagnostic and Therapeutic market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Crohn’s Disease Diagnostic and Therapeutic market.
Global Crohn’s Disease Diagnostic and Therapeutic Scope and Market Size
Crohn’s Disease Diagnostic and Therapeutic market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Crohn’s Disease Diagnostic and Therapeutic market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Blood Tests
Fecal Test
Colonoscopy
Flexible Sigmoidoscopy
Computerized Tomography
Magnetic Resonance Imaging
Capsule Endoscopy
Segment by Application
Clinic
Hospital
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
AbbVie
Celgene Corporation
Genetech
Janssen Biotech
Johnson & Johnson
Pfizer
Prometheus Laboratories
Salix Pharmaceuticals
Takeda’s Pharmaceutical
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Crohn’s Disease Diagnostic and Therapeutic Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Blood Tests
1.2.3 Fecal Test
1.2.4 Colonoscopy
1.2.5 Flexible Sigmoidoscopy
1.2.6 Computerized Tomography
1.2.7 Magnetic Resonance Imaging
1.2.8 Capsule Endoscopy
1.3 Market by Application
1.3.1 Global Crohn’s Disease Diagnostic and Therapeutic Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Clinic
1.3.3 Hospital
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Crohn’s Disease Diagnostic and Therapeutic Market Perspective (2016-2027)
2.2 Crohn’s Disease Diagnostic and Therapeutic Growth Trends by Regions
2.2.1 Crohn’s Disease Diagnostic and Therapeutic Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Crohn’s Disease Diagnostic and Therapeutic Historic Market Share by Regions (2016-2021)
2.2.3 Crohn’s Disease Diagnostic and Therapeutic Forecasted Market Size by Regions (2022-2027)
2.3 Crohn’s Disease Diagnostic and Therapeutic Industry Dynamic
2.3.1 Crohn’s Disease Diagnostic and Therapeutic Market Trends
2.3.2 Crohn’s Disease Diagnostic and Therapeutic Market Drivers
2.3.3 Crohn’s Disease Diagnostic and Therapeutic Market Challenges
2.3.4 Crohn’s Disease Diagnostic and Therapeutic Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Crohn’s Disease Diagnostic and Therapeutic Players by Revenue
3.1.1 Global Top Crohn’s Disease Diagnostic and Therapeutic Players by Revenue (2016-2021)
3.1.2 Global Crohn’s Disease Diagnostic and Therapeutic Revenue Market Share by Players (2016-2021)
3.2 Global Crohn’s Disease Diagnostic and Therapeutic Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Crohn’s Disease Diagnostic and Therapeutic Revenue
3.4 Global Crohn’s Disease Diagnostic and Therapeutic Market Concentration Ratio
3.4.1 Global Crohn’s Disease Diagnostic and Therapeutic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Crohn’s Disease Diagnostic and Therapeutic Revenue in 2020
3.5 Crohn’s Disease Diagnostic and Therapeutic Key Players Head office and Area Served
3.6 Key Players Crohn’s Disease Diagnostic and Therapeutic Product Solution and Service
3.7 Date of Enter into Crohn’s Disease Diagnostic and Therapeutic Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Crohn’s Disease Diagnostic and Therapeutic Breakdown Data by Type
4.1 Global Crohn’s Disease Diagnostic and Therapeutic Historic Market Size by Type (2016-2021)
4.2 Global Crohn’s Disease Diagnostic and Therapeutic Forecasted Market Size by Type (2022-2027)
5 Crohn’s Disease Diagnostic and Therapeutic Breakdown Data by Application
5.1 Global Crohn’s Disease Diagnostic and Therapeutic Historic Market Size by Application (2016-2021)
5.2 Global Crohn’s Disease Diagnostic and Therapeutic Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Crohn’s Disease Diagnostic and Therapeutic Market Size (2016-2027)
6.2 North America Crohn’s Disease Diagnostic and Therapeutic Market Size by Type
6.2.1 North America Crohn’s Disease Diagnostic and Therapeutic Market Size by Type (2016-2021)
6.2.2 North America Crohn’s Disease Diagnostic and Therapeutic Market Size by Type (2022-2027)
6.2.3 North America Crohn’s Disease Diagnostic and Therapeutic Market Size by Type (2016-2027)
6.3 North America Crohn’s Disease Diagnostic and Therapeutic Market Size by Application
6.3.1 North America Crohn’s Disease Diagnostic and Therapeutic Market Size by Application (2016-2021)
6.3.2 North America Crohn’s Disease Diagnostic and Therapeutic Market Size by Application (2022-2027)
6.3.3 North America Crohn’s Disease Diagnostic and Therapeutic Market Size by Application (2016-2027)
6.4 North America Crohn’s Disease Diagnostic and Therapeutic Market Size by Country
6.4.1 North America Crohn’s Disease Diagnostic and Therapeutic Market Size by Country (2016-2021)
6.4.2 North America Crohn’s Disease Diagnostic and Therapeutic Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Crohn’s Disease Diagnostic and Therapeutic Market Size (2016-2027)
7.2 Europe Crohn’s Disease Diagnostic and Therapeutic Market Size by Type
7.2.1 Europe Crohn’s Disease Diagnostic and Therapeutic Market Size by Type (2016-2021)
7.2.2 Europe Crohn’s Disease Diagnostic and Therapeutic Market Size by Type (2022-2027)
7.2.3 Europe Crohn’s Disease Diagnostic and Therapeutic Market Size by Type (2016-2027)
7.3 Europe Crohn’s Disease Diagnostic and Therapeutic Market Size by Application
7.3.1 Europe Crohn’s Disease Diagnostic and Therapeutic Market Size by Application (2016-2021)
7.3.2 Europe Crohn’s Disease Diagnostic and Therapeutic Market Size by Application (2022-2027)
7.3.3 Europe Crohn’s Disease Diagnostic and Therapeutic Market Size by Application (2016-2027)
7.4 Europe Crohn’s Disease Diagnostic and Therapeutic Market Size by Country
7.4.1 Europe Crohn’s Disease Diagnostic and Therapeutic Market Size by Country (2016-2021)
7.4.2 Europe Crohn’s Disease Diagnostic and Therapeutic Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Crohn’s Disease Diagnostic and Therapeutic Market Size (2016-2027)
8.2 Asia-Pacific Crohn’s Disease Diagnostic and Therapeutic Market Size by Type
8.2.1 Asia-Pacific Crohn’s Disease Diagnostic and Therapeutic Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Crohn’s Disease Diagnostic and Therapeutic Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Crohn’s Disease Diagnostic and Therapeutic Market Size by Type (2016-2027)
8.3 Asia-Pacific Crohn’s Disease Diagnostic and Therapeutic Market Size by Application
8.3.1 Asia-Pacific Crohn’s Disease Diagnostic and Therapeutic Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Crohn’s Disease Diagnostic and Therapeutic Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Crohn’s Disease Diagnostic and Therapeutic Market Size by Application (2016-2027)
8.4 Asia-Pacific Crohn’s Disease Diagnostic and Therapeutic Market Size by Region
8.4.1 Asia-Pacific Crohn’s Disease Diagnostic and Therapeutic Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Crohn’s Disease Diagnostic and Therapeutic Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Crohn’s Disease Diagnostic and Therapeutic Market Size (2016-2027)
9.2 Latin America Crohn’s Disease Diagnostic and Therapeutic Market Size by Type
9.2.1 Latin America Crohn’s Disease Diagnostic and Therapeutic Market Size by Type (2016-2021)
9.2.2 Latin America Crohn’s Disease Diagnostic and Therapeutic Market Size by Type (2022-2027)
9.2.3 Latin America Crohn’s Disease Diagnostic and Therapeutic Market Size by Type (2016-2027)
9.3 Latin America Crohn’s Disease Diagnostic and Therapeutic Market Size by Application
9.3.1 Latin America Crohn’s Disease Diagnostic and Therapeutic Market Size by Application (2016-2021)
9.3.2 Latin America Crohn’s Disease Diagnostic and Therapeutic Market Size by Application (2022-2027)
9.3.3 Latin America Crohn’s Disease Diagnostic and Therapeutic Market Size by Application (2016-2027)
9.4 Latin America Crohn’s Disease Diagnostic and Therapeutic Market Size by Country
9.4.1 Latin America Crohn’s Disease Diagnostic and Therapeutic Market Size by Country (2016-2021)
9.4.2 Latin America Crohn’s Disease Diagnostic and Therapeutic Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Crohn’s Disease Diagnostic and Therapeutic Market Size (2016-2027)
10.2 Middle East & Africa Crohn’s Disease Diagnostic and Therapeutic Market Size by Type
10.2.1 Middle East & Africa Crohn’s Disease Diagnostic and Therapeutic Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Crohn’s Disease Diagnostic and Therapeutic Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Crohn’s Disease Diagnostic and Therapeutic Market Size by Type (2016-2027)
10.3 Middle East & Africa Crohn’s Disease Diagnostic and Therapeutic Market Size by Application
10.3.1 Middle East & Africa Crohn’s Disease Diagnostic and Therapeutic Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Crohn’s Disease Diagnostic and Therapeutic Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Crohn’s Disease Diagnostic and Therapeutic Market Size by Application (2016-2027)
10.4 Middle East & Africa Crohn’s Disease Diagnostic and Therapeutic Market Size by Country
10.4.1 Middle East & Africa Crohn’s Disease Diagnostic and Therapeutic Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Crohn’s Disease Diagnostic and Therapeutic Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 AbbVie
11.1.1 AbbVie Company Details
11.1.2 AbbVie Business Overview
11.1.3 AbbVie Crohn’s Disease Diagnostic and Therapeutic Introduction
11.1.4 AbbVie Revenue in Crohn’s Disease Diagnostic and Therapeutic Business (2016-2021)
11.1.5 AbbVie Recent Development
11.2 Celgene Corporation
11.2.1 Celgene Corporation Company Details
11.2.2 Celgene Corporation Business Overview
11.2.3 Celgene Corporation Crohn’s Disease Diagnostic and Therapeutic Introduction
11.2.4 Celgene Corporation Revenue in Crohn’s Disease Diagnostic and Therapeutic Business (2016-2021)
11.2.5 Celgene Corporation Recent Development
11.3 Genetech
11.3.1 Genetech Company Details
11.3.2 Genetech Business Overview
11.3.3 Genetech Crohn’s Disease Diagnostic and Therapeutic Introduction
11.3.4 Genetech Revenue in Crohn’s Disease Diagnostic and Therapeutic Business (2016-2021)
11.3.5 Genetech Recent Development
11.4 Janssen Biotech
11.4.1 Janssen Biotech Company Details
11.4.2 Janssen Biotech Business Overview
11.4.3 Janssen Biotech Crohn’s Disease Diagnostic and Therapeutic Introduction
11.4.4 Janssen Biotech Revenue in Crohn’s Disease Diagnostic and Therapeutic Business (2016-2021)
11.4.5 Janssen Biotech Recent Development
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Company Details
11.5.2 Johnson & Johnson Business Overview
11.5.3 Johnson & Johnson Crohn’s Disease Diagnostic and Therapeutic Introduction
11.5.4 Johnson & Johnson Revenue in Crohn’s Disease Diagnostic and Therapeutic Business (2016-2021)
11.5.5 Johnson & Johnson Recent Development
11.6 Pfizer
11.6.1 Pfizer Company Details
11.6.2 Pfizer Business Overview
11.6.3 Pfizer Crohn’s Disease Diagnostic and Therapeutic Introduction
11.6.4 Pfizer Revenue in Crohn’s Disease Diagnostic and Therapeutic Business (2016-2021)
11.6.5 Pfizer Recent Development
11.7 Prometheus Laboratories
11.7.1 Prometheus Laboratories Company Details
11.7.2 Prometheus Laboratories Business Overview
11.7.3 Prometheus Laboratories Crohn’s Disease Diagnostic and Therapeutic Introduction
11.7.4 Prometheus Laboratories Revenue in Crohn’s Disease Diagnostic and Therapeutic Business (2016-2021)
11.7.5 Prometheus Laboratories Recent Development
11.8 Salix Pharmaceuticals
11.8.1 Salix Pharmaceuticals Company Details
11.8.2 Salix Pharmaceuticals Business Overview
11.8.3 Salix Pharmaceuticals Crohn’s Disease Diagnostic and Therapeutic Introduction
11.8.4 Salix Pharmaceuticals Revenue in Crohn’s Disease Diagnostic and Therapeutic Business (2016-2021)
11.8.5 Salix Pharmaceuticals Recent Development
11.9 Takeda’s Pharmaceutical
11.9.1 Takeda’s Pharmaceutical Company Details
11.9.2 Takeda’s Pharmaceutical Business Overview
11.9.3 Takeda’s Pharmaceutical Crohn’s Disease Diagnostic and Therapeutic Introduction
11.9.4 Takeda’s Pharmaceutical Revenue in Crohn’s Disease Diagnostic and Therapeutic Business (2016-2021)
11.9.5 Takeda’s Pharmaceutical Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Crohn's Disease Diagnostic and Therapeutic Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Blood Tests
Table 3. Key Players of Fecal Test
Table 4. Key Players of Colonoscopy
Table 5. Key Players of Flexible Sigmoidoscopy
Table 6. Key Players of Computerized Tomography
Table 7. Key Players of Magnetic Resonance Imaging
Table 8. Key Players of Capsule Endoscopy
Table 9. Global Crohn's Disease Diagnostic and Therapeutic Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Crohn's Disease Diagnostic and Therapeutic Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 11. Global Crohn's Disease Diagnostic and Therapeutic Market Size by Regions (2016-2021) & (US$ Million)
Table 12. Global Crohn's Disease Diagnostic and Therapeutic Market Share by Regions (2016-2021)
Table 13. Global Crohn's Disease Diagnostic and Therapeutic Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 14. Global Crohn's Disease Diagnostic and Therapeutic Market Share by Regions (2022-2027)
Table 15. Crohn's Disease Diagnostic and Therapeutic Market Trends
Table 16. Crohn's Disease Diagnostic and Therapeutic Market Drivers
Table 17. Crohn's Disease Diagnostic and Therapeutic Market Challenges
Table 18. Crohn's Disease Diagnostic and Therapeutic Market Restraints
Table 19. Global Crohn's Disease Diagnostic and Therapeutic Revenue by Players (2016-2021) & (US$ Million)
Table 20. Global Crohn's Disease Diagnostic and Therapeutic Market Share by Players (2016-2021)
Table 21. Global Top Crohn's Disease Diagnostic and Therapeutic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Crohn's Disease Diagnostic and Therapeutic as of 2020)
Table 22. Ranking of Global Top Crohn's Disease Diagnostic and Therapeutic Companies by Revenue (US$ Million) in 2020
Table 23. Global 5 Largest Players Market Share by Crohn's Disease Diagnostic and Therapeutic Revenue (CR5 and HHI) & (2016-2021)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Crohn's Disease Diagnostic and Therapeutic Product Solution and Service
Table 26. Date of Enter into Crohn's Disease Diagnostic and Therapeutic Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Crohn's Disease Diagnostic and Therapeutic Market Size by Type (2016-2021) (US$ Million)
Table 29. Global Crohn's Disease Diagnostic and Therapeutic Revenue Market Share by Type (2016-2021)
Table 30. Global Crohn's Disease Diagnostic and Therapeutic Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 31. Global Crohn's Disease Diagnostic and Therapeutic Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 32. Global Crohn's Disease Diagnostic and Therapeutic Market Size Share by Application (2016-2021) & (US$ Million)
Table 33. Global Crohn's Disease Diagnostic and Therapeutic Revenue Market Share by Application (2016-2021)
Table 34. Global Crohn's Disease Diagnostic and Therapeutic Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 35. Global Crohn's Disease Diagnostic and Therapeutic Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 36. North America Crohn's Disease Diagnostic and Therapeutic Market Size by Type (2016-2021) (US$ Million)
Table 37. North America Crohn's Disease Diagnostic and Therapeutic Market Size by Type (2022-2027) & (US$ Million)
Table 38. North America Crohn's Disease Diagnostic and Therapeutic Market Size by Application (2016-2021) (US$ Million)
Table 39. North America Crohn's Disease Diagnostic and Therapeutic Market Size by Application (2022-2027) & (US$ Million)
Table 40. North America Crohn's Disease Diagnostic and Therapeutic Market Size by Country (2016-2021) & (US$ Million)
Table 41. North America Crohn's Disease Diagnostic and Therapeutic Market Size by Country (2022-2027) & (US$ Million)
Table 42. Europe Crohn's Disease Diagnostic and Therapeutic Market Size by Type (2016-2021) (US$ Million)
Table 43. Europe Crohn's Disease Diagnostic and Therapeutic Market Size by Type (2022-2027) & (US$ Million)
Table 44. Europe Crohn's Disease Diagnostic and Therapeutic Market Size by Application (2016-2021) (US$ Million)
Table 45. Europe Crohn's Disease Diagnostic and Therapeutic Market Size by Application (2022-2027) & (US$ Million)
Table 46. Europe Crohn's Disease Diagnostic and Therapeutic Market Size by Country (2016-2021) & (US$ Million)
Table 47. Europe Crohn's Disease Diagnostic and Therapeutic Market Size by Country (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Crohn's Disease Diagnostic and Therapeutic Market Size by Type (2016-2021) (US$ Million)
Table 49. Asia-Pacific Crohn's Disease Diagnostic and Therapeutic Market Size by Type (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Crohn's Disease Diagnostic and Therapeutic Market Size by Application (2016-2021) (US$ Million)
Table 51. Asia-Pacific Crohn's Disease Diagnostic and Therapeutic Market Size by Application (2022-2027) & (US$ Million)
Table 52. Asia-Pacific Crohn's Disease Diagnostic and Therapeutic Market Size by Region (2016-2021) & (US$ Million)
Table 53. Asia-Pacific Crohn's Disease Diagnostic and Therapeutic Market Size by Region (2022-2027) & (US$ Million)
Table 54. Latin America Crohn's Disease Diagnostic and Therapeutic Market Size by Type (2016-2021) (US$ Million)
Table 55. Latin America Crohn's Disease Diagnostic and Therapeutic Market Size by Type (2022-2027) & (US$ Million)
Table 56. Latin America Crohn's Disease Diagnostic and Therapeutic Market Size by Application (2016-2021) (US$ Million)
Table 57. Latin America Crohn's Disease Diagnostic and Therapeutic Market Size by Application (2022-2027) & (US$ Million)
Table 58. Latin America Crohn's Disease Diagnostic and Therapeutic Market Size by Country (2016-2021) & (US$ Million)
Table 59. Latin America Crohn's Disease Diagnostic and Therapeutic Market Size by Country (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Crohn's Disease Diagnostic and Therapeutic Market Size by Type (2016-2021) (US$ Million)
Table 61. Middle East & Africa Crohn's Disease Diagnostic and Therapeutic Market Size by Type (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Crohn's Disease Diagnostic and Therapeutic Market Size by Application (2016-2021) (US$ Million)
Table 63. Middle East & Africa Crohn's Disease Diagnostic and Therapeutic Market Size by Application (2022-2027) & (US$ Million)
Table 64. Middle East & Africa Crohn's Disease Diagnostic and Therapeutic Market Size by Country (2016-2021) & (US$ Million)
Table 65. Middle East & Africa Crohn's Disease Diagnostic and Therapeutic Market Size by Country (2022-2027) & (US$ Million)
Table 66. AbbVie Company Details
Table 67. AbbVie Business Overview
Table 68. AbbVie Crohn's Disease Diagnostic and Therapeutic Product
Table 69. AbbVie Revenue in Crohn's Disease Diagnostic and Therapeutic Business (2016-2021) & (US$ Million)
Table 70. AbbVie Recent Development
Table 71. Celgene Corporation Company Details
Table 72. Celgene Corporation Business Overview
Table 73. Celgene Corporation Crohn's Disease Diagnostic and Therapeutic Product
Table 74. Celgene Corporation Revenue in Crohn's Disease Diagnostic and Therapeutic Business (2016-2021) & (US$ Million)
Table 75. Celgene Corporation Recent Development
Table 76. Genetech Company Details
Table 77. Genetech Business Overview
Table 78. Genetech Crohn's Disease Diagnostic and Therapeutic Product
Table 79. Genetech Revenue in Crohn's Disease Diagnostic and Therapeutic Business (2016-2021) & (US$ Million)
Table 80. Genetech Recent Development
Table 81. Janssen Biotech Company Details
Table 82. Janssen Biotech Business Overview
Table 83. Janssen Biotech Crohn's Disease Diagnostic and Therapeutic Product
Table 84. Janssen Biotech Revenue in Crohn's Disease Diagnostic and Therapeutic Business (2016-2021) & (US$ Million)
Table 85. Janssen Biotech Recent Development
Table 86. Johnson & Johnson Company Details
Table 87. Johnson & Johnson Business Overview
Table 88. Johnson & Johnson Crohn's Disease Diagnostic and Therapeutic Product
Table 89. Johnson & Johnson Revenue in Crohn's Disease Diagnostic and Therapeutic Business (2016-2021) & (US$ Million)
Table 90. Johnson & Johnson Recent Development
Table 91. Pfizer Company Details
Table 92. Pfizer Business Overview
Table 93. Pfizer Crohn's Disease Diagnostic and Therapeutic Product
Table 94. Pfizer Revenue in Crohn's Disease Diagnostic and Therapeutic Business (2016-2021) & (US$ Million)
Table 95. Pfizer Recent Development
Table 96. Prometheus Laboratories Company Details
Table 97. Prometheus Laboratories Business Overview
Table 98. Prometheus Laboratories Crohn's Disease Diagnostic and Therapeutic Product
Table 99. Prometheus Laboratories Revenue in Crohn's Disease Diagnostic and Therapeutic Business (2016-2021) & (US$ Million)
Table 100. Prometheus Laboratories Recent Development
Table 101. Salix Pharmaceuticals Company Details
Table 102. Salix Pharmaceuticals Business Overview
Table 103. Salix Pharmaceuticals Revenue in Crohn's Disease Diagnostic and Therapeutic Business (2016-2021) & (US$ Million)
Table 104. Salix Pharmaceuticals Recent Development
Table 105. Takeda's Pharmaceutical Company Details
Table 106. Takeda's Pharmaceutical Business Overview
Table 107. Takeda's Pharmaceutical Crohn's Disease Diagnostic and Therapeutic Product
Table 108. Takeda's Pharmaceutical Revenue in Crohn's Disease Diagnostic and Therapeutic Business (2016-2021) & (US$ Million)
Table 109. Takeda's Pharmaceutical Recent Development
Table 110. Research Programs/Design for This Report
Table 111. Key Data Information from Secondary Sources
Table 112. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Crohn's Disease Diagnostic and Therapeutic Market Share by Type: 2020 VS 2027
Figure 2. Blood Tests Features
Figure 3. Fecal Test Features
Figure 4. Colonoscopy Features
Figure 5. Flexible Sigmoidoscopy Features
Figure 6. Computerized Tomography Features
Figure 7. Magnetic Resonance Imaging Features
Figure 8. Capsule Endoscopy Features
Figure 9. Global Crohn's Disease Diagnostic and Therapeutic Market Share by Application: 2020 VS 2027
Figure 10. Clinic Case Studies
Figure 11. Hospital Case Studies
Figure 12. Crohn's Disease Diagnostic and Therapeutic Report Years Considered
Figure 13. Global Crohn's Disease Diagnostic and Therapeutic Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 14. Global Crohn's Disease Diagnostic and Therapeutic Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Crohn's Disease Diagnostic and Therapeutic Market Share by Regions: 2020 VS 2027
Figure 16. Global Crohn's Disease Diagnostic and Therapeutic Market Share by Regions (2022-2027)
Figure 17. Global Crohn's Disease Diagnostic and Therapeutic Market Share by Players in 2020
Figure 18. Global Top Crohn's Disease Diagnostic and Therapeutic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Crohn's Disease Diagnostic and Therapeutic as of 2020
Figure 19. The Top 10 and 5 Players Market Share by Crohn's Disease Diagnostic and Therapeutic Revenue in 2020
Figure 20. Global Crohn's Disease Diagnostic and Therapeutic Revenue Market Share by Type (2016-2021)
Figure 21. Global Crohn's Disease Diagnostic and Therapeutic Revenue Market Share by Type (2022-2027)
Figure 22. North America Crohn's Disease Diagnostic and Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. North America Crohn's Disease Diagnostic and Therapeutic Market Share by Type (2016-2027)
Figure 24. North America Crohn's Disease Diagnostic and Therapeutic Market Share by Application (2016-2027)
Figure 25. North America Crohn's Disease Diagnostic and Therapeutic Market Share by Country (2016-2027)
Figure 26. United States Crohn's Disease Diagnostic and Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Canada Crohn's Disease Diagnostic and Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Crohn's Disease Diagnostic and Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Crohn's Disease Diagnostic and Therapeutic Market Share by Type (2016-2027)
Figure 30. Europe Crohn's Disease Diagnostic and Therapeutic Market Share by Application (2016-2027)
Figure 31. Europe Crohn's Disease Diagnostic and Therapeutic Market Share by Country (2016-2027)
Figure 32. Germany Crohn's Disease Diagnostic and Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. France Crohn's Disease Diagnostic and Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. U.K. Crohn's Disease Diagnostic and Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Italy Crohn's Disease Diagnostic and Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Russia Crohn's Disease Diagnostic and Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Nordic Crohn's Disease Diagnostic and Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Crohn's Disease Diagnostic and Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Crohn's Disease Diagnostic and Therapeutic Market Share by Type (2016-2027)
Figure 40. Asia-Pacific Crohn's Disease Diagnostic and Therapeutic Market Share by Application (2016-2027)
Figure 41. Asia-Pacific Crohn's Disease Diagnostic and Therapeutic Market Share by Region (2016-2027)
Figure 42. China Crohn's Disease Diagnostic and Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Japan Crohn's Disease Diagnostic and Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. South Korea Crohn's Disease Diagnostic and Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Southeast Asia Crohn's Disease Diagnostic and Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. India Crohn's Disease Diagnostic and Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Australia Crohn's Disease Diagnostic and Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Crohn's Disease Diagnostic and Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Crohn's Disease Diagnostic and Therapeutic Market Share by Type (2016-2027)
Figure 50. Latin America Crohn's Disease Diagnostic and Therapeutic Market Share by Application (2016-2027)
Figure 51. Latin America Crohn's Disease Diagnostic and Therapeutic Market Share by Country (2016-2027)
Figure 52. Mexico Crohn's Disease Diagnostic and Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Brazil Crohn's Disease Diagnostic and Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Crohn's Disease Diagnostic and Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Crohn's Disease Diagnostic and Therapeutic Market Share by Type (2016-2027)
Figure 56. Middle East & Africa Crohn's Disease Diagnostic and Therapeutic Market Share by Application (2016-2027)
Figure 57. Middle East & Africa Crohn's Disease Diagnostic and Therapeutic Market Share by Country (2016-2027)
Figure 58. Turkey Crohn's Disease Diagnostic and Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Saudi Arabia Crohn's Disease Diagnostic and Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. UAE Crohn's Disease Diagnostic and Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. AbbVie Revenue Growth Rate in Crohn's Disease Diagnostic and Therapeutic Business (2016-2021)
Figure 62. Celgene Corporation Revenue Growth Rate in Crohn's Disease Diagnostic and Therapeutic Business (2016-2021)
Figure 63. Genetech Revenue Growth Rate in Crohn's Disease Diagnostic and Therapeutic Business (2016-2021)
Figure 64. Janssen Biotech Revenue Growth Rate in Crohn's Disease Diagnostic and Therapeutic Business (2016-2021)
Figure 65. Johnson & Johnson Revenue Growth Rate in Crohn's Disease Diagnostic and Therapeutic Business (2016-2021)
Figure 66. Pfizer Revenue Growth Rate in Crohn's Disease Diagnostic and Therapeutic Business (2016-2021)
Figure 67. Prometheus Laboratories Revenue Growth Rate in Crohn's Disease Diagnostic and Therapeutic Business (2016-2021)
Figure 68. Salix Pharmaceuticals Revenue Growth Rate in Crohn's Disease Diagnostic and Therapeutic Business (2016-2021)
Figure 69. Takeda's Pharmaceutical Revenue Growth Rate in Crohn's Disease Diagnostic and Therapeutic Business (2016-2021)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed
世界のクローン病診断・治療市場規模・現状・予測（2021年-2027年） Crohn’s disease (CD) is an inflammatory bowel disease (IBD) that can affect any part of the gastrointestinal tract from mouth to the anus. It is caused by a combination of environmental, immune, and bacterial factors, in genetically predisposed individuals. Market Analysis and Insights: Global Crohn…- 世界のクローン病市場規模・現状・予測（2021年-2027年） Crohn’s disease refers to long term inflammatory bowel disease, which causes inflammation of the lining of the digestive tract. It affects the large and small intestine and is generally diagnosed in persons within the age group of 20-29. It can have severe or acute outcomes. Signs and symptoms of Cr…
- 世界の便潜血（FOBT）迅速診断検査市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Fecal Occult Blood (FOBT) Rapid Diagnostic Test Market The global Fecal Occult Blood (FOBT) Rapid Diagnostic Test market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accu…
- 世界の腸疾患検査・治療市場規模・現状・予測（2021年-2027年） Enteric diseases are the infections caused by ingestion of contaminated food or water. These infections are commonly caused by bacteria and viruses. Poor maintenance of hygiene and sanitation, particularly due to rising population and urbanization is increasing the prevalence of enteric diseases. Ac…
- 世界のクローン病治療市場 2021：企業別、地域別、種類・用途別 The Crohn’s Disease Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade re…